Dr. Sulaiman Al Habib Medical Services Group (4013.SR) Earnings Analysis

Dr. Sulaiman Al Habib Medical Services Group (4013.SR) next reports earnings on 2026-08-03, consensus EPS 1.73 SAR. Last quarter (2026-05-03) it missed with EPS 1.43 SAR vs 1.97 SAR est (-27.4%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 32.01.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4013.SR next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate1.73 SAR
Revenue estimate3.71B

4013.SR earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-031.43 SAR1.97 SAR-27.4%Miss
2026-02-151.86 SAR1.76 SAR+5.7%Beat
2025-10-261.72 SAR1.77 SAR-2.8%Miss
2025-07-271.69 SAR1.63 SAR+3.7%Beat
2025-05-041.59 SAR1.73 SAR-8.1%Miss
2025-02-171.75 SAR1.62 SAR+8%Beat
2024-11-031.7 SAR1.72 SAR-1.2%Miss
2024-07-281.74 SAR1.52 SAR+14.5%Beat

Beat rate: 4/8 (50%) over reported quarters with consensus data.

4013.SR valuation and analyst view

Trailing P/E32.01
Trailing EPS6.708 SAR
Price / book9.46
Dividend yield2.20%
Market cap74.31B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Dr. Sulaiman Al Habib Medical Services Group (4013.SR)'s next earnings date?

Dr. Sulaiman Al Habib Medical Services Group is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 1.73 SAR and revenue estimate of 3.71B.

Did 4013.SR beat earnings last quarter?

In its 2026-05-03 report, 4013.SR posted EPS of 1.43 SAR versus a 1.97 SAR estimate — a miss of 27.4%.

What is 4013.SR's earnings track record?

Over the last 8 reported quarters with consensus data, 4013.SR beat estimates 4 times (50%).

What is 4013.SR's current P/E ratio and EPS?

4013.SR trades at a trailing P/E of 32.01 on trailing EPS of 6.707867617142857 SAR.

What do analysts rate 4013.SR?

4013.SR has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.